INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,208 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
EM
Elwart Ryan MichaelGroup President
MATVMativ Holdings, Inc.
Grant or award
A—
28.9K sh
Feb 24, 2026Feb 26, 2026
Page 1217 of 1756
← PrevNext →
traded Feb 24, 2026
+2d
SEC Form 4

Evidence

9
SB
Saenger BradleyChief Financial Officer
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
39.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
LR
Lima Cynthia ReneeSVP, Ext. Affairs & Comm.
ALBALBEMARLE CORP
Tax withholding
F$27K
144 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
RJ
Rambeau JonPres., Coms. & Spec. Dom.
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Option exercise
M—
3,034 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
PD
Pfeiffer DeborahEVP & Pres, Presort Services
PBIPITNEY BOWES INC /DE/
Option exercise
M—
3,805 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
LR
Lima Cynthia ReneeSVP, Ext. Affairs & Comm.
ALBALBEMARLE CORP
Tax withholding
F$37K
196 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

9
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Grant or award
A—
62.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

8
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
1,274 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
677 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

8
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
2,548 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
BC
Brown ChristianDirector, Chief Executive Officer
CTRICenturi Holdings, Inc.
Tax withholding
F$151K
4,893 sh
Feb 25, 2026Feb 26, 2026
traded Feb 25, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$7,539
183 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
644 sh
Feb 26, 2026Feb 26, 2026
traded Feb 26, 2026
+0dSEC Form 4

Evidence

7
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Grant or award · 10b5-1 plan
A—
30.5K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
CE
Cho EstherChief Legal Officer
KROSKeros Therapeutics, Inc.
Grant or award
A—
80.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Grant or award
A—
44.8K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
TO
Tkach OxanaPRINCIPAL ACCOUNTING OFFICER
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$8,955
5,625 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
MS
Mehta SamirPres., Space & Mission Sys.
LHXL3HARRIS TECHNOLOGIES, INC. /DE/
Option exercise
M—
3,034 sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

5
LR
Lerner Lorena RaquelChief Scientific Officer
KROSKeros Therapeutics, Inc.
Grant or award
A—
75.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

4
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Grant or award · 10b5-1 plan
A—
59.9K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

0
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Grant or award · 10b5-1 plan
A—
26.1K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC Form 4

Evidence

53
GL
Goldberg LouisDirector
GSHDGoosehead Insurance, Inc.
Open-market purchase
BUY$250K
5,575 sh
Feb 20, 2026Feb 25, 2026
traded Feb 20, 2026
+5dSEC Form 4

Evidence

47
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Open-market sale
SELL$1.53M
4,600 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

41
CD
Carter DeonVP & President CAPV
OLNOLIN Corp
Open-market sale
SELL$154K
6,500 sh
Feb 25, 2026Feb 25, 2026
traded Feb 25, 2026
+0dSEC Form 4

Evidence

40
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Open-market sale
SELL$534K
1,601 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

40
TS
Trickett SaraChief Legal Officer
WEXWEX Inc.
Open-market sale
SELL$272K
1,815 sh
Feb 25, 2026Feb 25, 2026
traded Feb 25, 2026
+0dSEC Form 4

Evidence

36
SK
Shetty Sanjay KPresident, CenterWell
HUMHUMANA INC
Open-market purchase
BUY$150K
810 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

35
BL
Brown Douglas LewisDirector
SOSSOS Ltd
Open-market sale
SELL$21K
12.9K sh
Jan 28, 2026Feb 25, 2026
traded Jan 28, 2026
+28dSEC Form 4

Evidence

34
RB
Ragsdale BruceChief Operating Officer
ICHRICHOR HOLDINGS, LTD.
Open-market sale
SELL$1.06M
21.3K sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

33
SG
Satterwhite John GibsonEVP, ASSET MANAGEMENT
LTCLTC PROPERTIES INC
Grant or award
A$415K
10.7K sh
Feb 19, 2026Feb 25, 2026
traded Feb 19, 2026
+6dSEC Form 4

Evidence

32
BS
Bowman Erica SVICE PRESIDENT
EIXEDISON INTERNATIONAL
Open-market sale
SELL$94K
1,276 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

32
WA
Wilkinson AllenSVP, CHIEF ACCOUNTING OFFICER
CBOECboe Global Markets, Inc.
Open-market sale
SELL$73K
248 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

31
BJ
Benjamin David JEVP, Chief Commercial Officer
BLKBBLACKBAUD INC
Open-market sale
SELL$681K
14.3K sh
Feb 24, 2026Feb 25, 2026
traded Feb 24, 2026
+1dSEC Form 4

Evidence

30
CS
Cohen StephenSenior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$241K
225 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

30
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M$1.22M
4,600 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

29
BR
Brenner RobertChief Medical Officer
VERAVera Therapeutics, Inc.
Open-market sale
SELL$90K
2,151 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

29
SM
Skelton Laurence MatthewChief Commercial Officer
VERAVera Therapeutics, Inc.
Open-market sale
SELL$66K
1,582 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

28
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale
SELL$130K
2,500 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

27
TS
Trickett SaraChief Legal Officer
WEXWEX Inc.
Grant or award
A$398K
2,625 sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence

26
LC
Larsen Larry CExecutive Vice President & COO
WMBWILLIAMS COMPANIES, INC.
Option exercise
M$2.70M
36.9K sh
Feb 23, 2026Feb 25, 2026
traded Feb 23, 2026
+2dSEC Form 4

Evidence